Evolutionary analysis of human vascular endothelial growth factor, angiopoietin, and tyrosine endothelial kinase involved in angiogenesis and immunity

In Silico Biology

Volumn 5, Issue 3, 2005, Pages 323-339

  Dormer, Anton ^a   Beck, Gregory ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

Angiogenesis; Angiopoietin; Cytokine; Endothelial growth factor; Evolution; Human vascular endothelial growth factor; Immunology; Invertebrate; Protein sequence; Tyrosine endothelial kinase; Vascular homeostasis; Vascular integrity

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; COMPUTER PROGRAM; ENZYME ACTIVITY; EVOLUTIONARY HOMOLOGY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNITY; INFORMATION RETRIEVAL; MOLECULAR EVOLUTION; PHYLOGENETIC TREE; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ALGORITHMS; AMINO ACID SEQUENCE; ANGIOPOIETINS; ANIMALS; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PHYLOGENY; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE HOMOLOGY, AMINO ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23744487285     PISSN: 13866338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Altschul, S. F. and Lipman, D. J. (1990). Protein database searches for multiple alignments. Proc. Natl. Acad. Sci. USA 87, 5509-55013.
2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
3. Angelucci, C., Lama, G., Iacopino, F., Maglione, D. and Sica, G. (2001). Effect of placenta growth factor-1 on proliferation and release of nitric oxide, cyclic AMP and cyclic GMP in human epithelial cells expressing the FLT-1 receptor. Growth Factors 19, 193-206.
4. Brodsky, L. I., Vasiliev, A. V., Kalaidzidis, Y. L., Osipov, Y. S., Tatuzov, R. L. and Feranchuk, S.I. (1992). GeneBee: The program package for biopolymer structure analysis. Dimacs. 8, 127-139.
5. Brodsky, L. I., Ivanov, V. V., Kalaidzidis, Y. L., Leontovich, A. M., Nikolaev, V. K., Feranchuk, S. I. and Drachev, V. A. (1995). GeneBee-NET: Internet-based server for analyzing biopolymers structure. Biochemistry Mosc. 60, 923-928.
6. Cavallo, F., Quaglino, E., Cifaldi, L., DiCarlo, E., Andre, A., Bernabei, P., Musiani, P., Forni, G. and Calogero, R. A. (2001). Interleukin 12-activated lymphocytes influence tumor genetic programs. Cancer Res. 61, 3518-3523.
7. Cho, N. K., Keyes, L., Johnson, E., Heller, J., Ryner L. and Karim, F. (2002). Developmental control of blood cell migration by Drosophila VEGF pathway. Cell 108, 865-876
8. Christensen, R. A., Fujikawa, K., Madore, R., Oettgen, P. and Varticovski, L. (2002). NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: A potential mechanism for Tie2 regulation during hypoxia. J. Cell. Biochem. 85, 505-515.
9. Chumakov, K. M. and Iushmanov, S. V. (1988). The maximum topological similarity principle in molecular systematics. Mol. Gen. Mikrobiol. Virusol. 3, 3-9.
10. Cope, M. J., Whisstock, J., Rayment, I. and Kendrick-Jones, J. (1996). Conservation within the myosin motor domain: Implications for structure and function. Structure 4, 969-987.
11. Cutler, D. J. (2000a). Estimating divergence times in the presence of an over dispersed molecular clock. Mol. Biol. Evol. 17, 1647-1660.
12. Cutler D. J. (2000b). Understanding the over dispersed molecular clock. Genetics 154, 1403-1417.
13. Dayhoff, M. O., Schwartz, R. M. and Orcutt, B. C. (1978). A Model of Evolutionary Change in Proteins. In: Atlas of Protein Sequence and Structure Vol. 5 suppl. 2, Dayhoff, M.O. (ed.), National Biomedical Research Foundation, Washington, D.C., pp. 345-352.
14. Felsenstein, J. (1989). PHYLIP (Phylogeny Inference Package) version 3.2. Cladistics 5, 164-166.
15. Felsenstein, J. (1993). PHYLIP (Phylogeny Inference Package) version 3.5c. Distributed by the author. Department of Genetics, University of Washington, Seattle.
16. Feoktistov, I., Ryzhov, S., Goldstein, A. E. and Biaggioni, I. (2003). Mast cell-mediated stimulation of angiogenesis: Cooperative interaction between A2B and A3 adenosine receptors. Circ. Res. 92, 485-492.
17. Gonnet, G. H., Cohen, M. A. and Benner, S. A. (1992). Exhaustive matching of the entire protein sequence database. Science 256, 1443-1445.
18. Hatanaka, H., Abe, Y., Naruke, M., Tokunaga, T., Oshika, Y., Kawakami, T., Osada, H., Nagata, J., Kamochi, J., Tsuchida, T., Kijima, H., Yamazaki, H., Inoue, H., Ueyama, Y. and Nakamura, M. (2001). Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. Clin. Cancer Res. 7, 1287-1292.
19. Hewett, P., Nijjar, S., Shams, M., Morgan, S., Gupta, J. and Ahmed, A. (2002). Down-regulation of angiopoietin-1 expression in menorrhagia. Am. J. Pathol. 160, 773-80.
20. Hodge, T. and Cope, M. J. (2000). Myosin family tree. J. Cell Sci. 113, 3353-3354.
21. Iushmanov, S. V. and Chumakov, K. M. (1988). Algorithms for constructing phylogenetic trees of maximum topological similarity. Mol. Genet. Mikrobiol. Virusol. 3, 9-15.
22. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
23. Kim, I., Kim, J. H., Ryu, Y. S., Liu, M. and Koh, G. Y. (2000). Tumor necrosis factor-α upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 269, 361-365.
24. Koonin, E. V., Makarova, K. S., Rogozin, I. B., Davidovic, L., Letellier, M-C. and Pellegrini, L. (2003). The rhomboids: A nearly ubiquitous family of intramembrane serine proteases that probably evolved by multiple ancient horizontal gene transfers. Genome Biol. 4, R19.
25. Levitas, E., Chamoun, D., Udoff, L. C., Ando, M., Resnick, C. E. and Adashi, E. Y. (2000). Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: Potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability. J. Soc. Gynecol. Investig. 7,, 51-60.
26. Nishimura, M., Miki, T., Yashima, R., Yokoi, N., Yano, H., Sato, Y. and Seino, S. (1999). Angiopoietin-3, a novel member of the angiopoietin family. FEBS Lett. 448, 254-256.
27. Okamoto, T., Niu, R., Mizutani, S. and Yamada, S. (2003). Levels of placenta growth factor in gestational trophoblastic diseases. Am. J. Obstet. Gynecol. 188, 135-140.
28. Ottaviani, E., Franchini, A. and Kletsas, D. (2001). Platelet-derived growth factor and transforming growth factor-b in invertebrate immune and neuroendocrine interations: Another sign of conservation in evolution. Comp. Biochem. Physiol. C. 129, 295-306.
29. Paradis, V., Bièche, I., Dargère, D., Laurendeau, I., Nectoux, J., Degott, C., Belghiti, J., Vidaud, M. and Bedossa, P. (2003). A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 124, 651-659.
30. Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Van Marck, E. and Dirix, L. Y. (1999). Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer 80, 892-897.
31. Salven, P., Hattori, K., Heissig, B. and Rafii, S. (2002). Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16,,, 1471-1473.
32. Satchell, S. C., Harper, S. J. and Mathieson, P. W. (2001). Angiopoietin-1 is normally expressed by periendothelial cells. Thromb. Haemost. 86, 1597-1598.
33. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
34. Scott, B. B., Zaratin, P. F., Colombo, A., Hansbury, M. J., Winkler, J. D. and Jackson, J. R. (2002). Constitutive expression of angiopoietin-1 and -2 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts. J. Rheumatol. 29, 230-239.
35. Shim, W. S., Teh, M., Bapna, A., Kim, I., Koh, G. Y., Mack, P. O. and Ge, R. (2002). Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. Exp. Cell. Res. 279, 299-309.
36. Stoeltzing, O., Ahmad, S. A., Liu, W., McCarty, M. F., Parikh, A. A., Fan, F., Remmuth, N., Bucana, C. D. and Ellis L. M. (2002). Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Br. J. Cancer 87, 1182-1187.
37. Su, Y. N., Hsu, J. J., Lee, C. N., Cheng, W. F., Kung, C. C. and Hsieh, F. J. (2002). Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome. Prenat. Diagn. 22, 8-12.
38. Taylor, R. N., Grimwood, J., Taylor, R. S., McMaster, M. T., Fisher, S. J. and North, R. A. (2003). Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol. 188, 177-182.
39. Tettamanti, G., Grimaldi, A., Valvassori, R., Rinaldi, L. and de Eguileor, M. (2003). Vascular endothelial growth factor is involved in neoangiogenesis in Hirudo medicinalis (Annelida, Hirudinea). Cytokine 22, 168-179.
40. Thurston, G. (2002). Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J. Anat. 200, 575-580.
41. Tian, S., Hayes, A. J., Metheny-Barlow, L. J. and Li, L. Y. (2002). Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br. J. Cancer 86, 645-651.
42. Tsiamis, A. C., Morris, P. N., Marron, M. B. and Brindle, N. P. (2002). Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc. Res. 63, 149-158.
43. Valenzuela, D. M., Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Huang, T., Papadopoulos, N., Maisonpierre, P. C., Davis, S. and Yancopoulos, G. D. (1999). Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96, 1904-1909.
44. Vinores, S. A., Derevjanik, N. L., Shi, A., Vinores, M. A., Klein, D. A. and Whittum-Hudson, J. A. (2001). Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpes virus retinopathy: Association with inflammation and viral infection. Histol. Histopathol. 16, 1061-1071.
45. Yokoyama, Y., Charnock-Jones, D. S., Licence, D., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., Umemoto, M., Sakamoto, T., Sato, S., Mizunuma, H. and Smith, S. K. (2003). Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br. J. Cancer. 88, 237-244.